NO20022949L - Attenuerte mikroorganismer for behandling av infeksjon - Google Patents

Attenuerte mikroorganismer for behandling av infeksjon

Info

Publication number
NO20022949L
NO20022949L NO20022949A NO20022949A NO20022949L NO 20022949 L NO20022949 L NO 20022949L NO 20022949 A NO20022949 A NO 20022949A NO 20022949 A NO20022949 A NO 20022949A NO 20022949 L NO20022949 L NO 20022949L
Authority
NO
Norway
Prior art keywords
infection
treatment
attenuated microorganisms
microorganism
microorganisms
Prior art date
Application number
NO20022949A
Other languages
English (en)
Other versions
NO20022949D0 (no
Inventor
Gordon Dougan
Joseph David Santagelo
Jacqueline Elizabeth Shea
Francis Richard Brennan
David William Holden
Original Assignee
Microscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930458.6A external-priority patent/GB9930458D0/en
Priority claimed from GBGB9930455.2A external-priority patent/GB9930455D0/en
Priority claimed from GBGB9930459.4A external-priority patent/GB9930459D0/en
Priority claimed from GBGB9930457.8A external-priority patent/GB9930457D0/en
Priority claimed from GBGB9930461.0A external-priority patent/GB9930461D0/en
Priority claimed from GBGB9930460.2A external-priority patent/GB9930460D0/en
Priority claimed from GBGB9930456.0A external-priority patent/GB9930456D0/en
Application filed by Microscience Ltd filed Critical Microscience Ltd
Publication of NO20022949D0 publication Critical patent/NO20022949D0/no
Publication of NO20022949L publication Critical patent/NO20022949L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/42—Salmonella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Dobbelt mutante Sa/mone//a-mikroorganismer hjelper til å forhindre reaktivitet til mikroorganismen mens de opprettholder effektiviteten av mikroorganismen til å fremkalle en immunrespons. Forskjellige spesifikke kombinasjoner av mutanten er fordelaktig.
NO20022949A 1999-12-23 2002-06-19 Attenuerte mikroorganismer for behandling av infeksjon NO20022949L (no)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GBGB9930458.6A GB9930458D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930455.2A GB9930455D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930459.4A GB9930459D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930457.8A GB9930457D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930461.0A GB9930461D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930460.2A GB9930460D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
GBGB9930456.0A GB9930456D0 (en) 1999-12-23 1999-12-23 Vaccine compositions
PCT/GB2000/005002 WO2001047962A2 (en) 1999-12-23 2000-12-22 Attenuated microorganisms for the treatment of infection

Publications (2)

Publication Number Publication Date
NO20022949D0 NO20022949D0 (no) 2002-06-19
NO20022949L true NO20022949L (no) 2002-06-19

Family

ID=27562965

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022949A NO20022949L (no) 1999-12-23 2002-06-19 Attenuerte mikroorganismer for behandling av infeksjon

Country Status (17)

Country Link
US (1) US20030059442A1 (no)
EP (1) EP1240192A2 (no)
JP (1) JP2003518933A (no)
KR (1) KR20020079755A (no)
CN (1) CN1411468A (no)
AP (1) AP2002002549A0 (no)
AU (1) AU2210001A (no)
BR (1) BR0016616A (no)
CA (1) CA2395382A1 (no)
CZ (1) CZ20022444A3 (no)
EA (1) EA200200704A1 (no)
HK (1) HK1046913A1 (no)
HU (1) HUP0203646A2 (no)
NO (1) NO20022949L (no)
NZ (1) NZ519477A (no)
OA (1) OA12130A (no)
WO (1) WO2001047962A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02008748A (es) 2000-03-17 2003-02-24 Upjohn Co Materiales y metodos para vacuna antisalmonella.
EP1640013A3 (en) * 2000-03-17 2007-02-21 Pharmacia & Upjohn Company LLC Inactivated Salmonella vaccines
WO2002026251A1 (en) * 2000-09-29 2002-04-04 Microscience Limited Attenuated salmonella microorganisms comprising a mutation in the sifa gene
WO2008118592A2 (en) * 2007-02-23 2008-10-02 The Penn State Research Foundation Use of an avirulent bordetella mutant as a live vaccine vector
MX2017002594A (es) * 2014-08-29 2017-05-19 Univ California Vacuna para sistemas de produccion ganadera.
KR102424707B1 (ko) * 2020-10-12 2022-07-25 전북대학교산학협력단 표적단백질발현을 증가시킨 진핵세포질 내 다중항원발현용 재조합벡터 및 진핵세포 내 벡터전달시스템용 살모넬라 티피뮤리움의 조합 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8912330D0 (en) * 1989-05-30 1989-07-12 Wellcome Found Live vaccines

Also Published As

Publication number Publication date
EP1240192A2 (en) 2002-09-18
JP2003518933A (ja) 2003-06-17
OA12130A (en) 2006-05-05
WO2001047962A2 (en) 2001-07-05
HUP0203646A2 (hu) 2003-03-28
WO2001047962A3 (en) 2002-05-10
WO2001047962A8 (en) 2002-10-31
US20030059442A1 (en) 2003-03-27
NO20022949D0 (no) 2002-06-19
CN1411468A (zh) 2003-04-16
BR0016616A (pt) 2002-10-29
NZ519477A (en) 2004-04-30
HK1046913A1 (zh) 2003-01-30
AU2210001A (en) 2001-07-09
CZ20022444A3 (cs) 2002-10-16
CA2395382A1 (en) 2001-07-05
KR20020079755A (ko) 2002-10-19
AP2002002549A0 (en) 2002-06-30
EA200200704A1 (ru) 2003-08-28

Similar Documents

Publication Publication Date Title
DE69831506D1 (en) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
ATE421883T1 (de) Beta-glucan enthaltende zusammenstellungen und spezifische immunoglobuline
BR9713391A (pt) Métodos e composições de detoxificação de zearalenona
NZ506058A (en) Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
AU2119200A (en) Medicament
DE69635419D1 (de) Alkalophile und thermophile mikroorganismen und damit erhaltene enzymen
EA200101187A1 (ru) Аттенюированные микроорганизмы для лечения инфекции
ES2184106T3 (es) Utilizacion del derivado de k-252a en el tratamiento de trastornos del sistema nervioso periferico o central, y de la hiperproduccion de citoquinas.
AU3304400A (en) Tetrahydropyran derivatives and their use as therapeutic agents
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
NO20022949L (no) Attenuerte mikroorganismer for behandling av infeksjon
MY129859A (en) Bacterial strains of the bacterium bacillus thuringiensis and uses therefor
MX9708611A (es) Compuestos de dialquiltiacumicina.
BR0005792A (pt) Método para a eliminação de staphylococcus aureus, microorganismo do gênero brachybacterium, e peça de roupa protetora, folha protetora ou roupa de cama protetora, cada uma sendo imobilizada com microorganismo do gênero brachybacterium
PL377176A1 (pl) N-Sulfonylo-4-metylenoamino-3-hydroksy-2-pirydony
TR200200300T2 (tr) İshali önlemeye elverişli bifidobakteriler.
EP0971725A4 (en) METHOD FOR TREATING SCAR TISSUE
MX9704061A (es) Bacterias productoras de rtx atenuadas vivas de la familia pasteurellaceae.
NZ515727A (en) Aminotetralin derivative for the therapy of cardiovascular diseases
AU5058698A (en) Use of pvp or povidone for reducing bowel distension
ES2149978T3 (es) Nuevo tiodepsipeptido aislado a partir de un actinomiceto marino.
ES2143916A1 (es) Derivados de benzopiranona producidos por microorganismos, procedimientos para su obtencion y uso como inhibidores de metalobetalactamasas.
AU2003204710A1 (en) Attenuated microorganisms for the treatment of infection
RU97113452A (ru) Штамм bacillus subtilis pac, резистентный к рифампицину, ампициллину и стрептомицину, обладающий антибактериальной активностью по отношению к патогенным видам микроорганизмов

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application